Home | Survey | Payment| Talks & Presentations | Job Opportunities
Journals   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Drug Evaluation
1672-2809
2008 Issue 11
zhuan jia ju jing cheng , zai lun xiao ke wan
tang hao
..............page:542
Effect of blood-glucose monitoring in type 2 diabetic patients
LU Zu-qian;XO Zhang-rong
..............page:525-528
Prevention of acute diabetic complications
FENG jian-ping
..............page:518-520
Glucose control in patients during the acute phase of stroke
ZHU Da-long;BI Yan
..............page:512-513
Re-understanding of metformin for type 2 diabetes mellitus
ZHAO Zhi-gang
..............page:510-511
The new usage of NovoMix 30: thrice daily injection
SU Jie-ying;LI Hong-liang;YANG Wen-ying
..............page:508-509
Periodontal disease and diabetes
SHEN Xiao-xia;LI Hong-liang;LI Guang-wei
..............page:506-507
Glucagon-like peptide-1 analog: new drug for diabetes mellitus
WANG Hui;LI Hong-liang;LI Guang-wei
..............page:504-505
Is drinking acceptable for diabetes?
HOU Zhi-qiang;LI Hong-liang;LI Guang-wei
..............page:503-504
The Banting medal for scientific achievement award: report from Ralph A DeFronzo
HOU Zhi-qiang;LI Hong-liang;LI Guang-wei
..............page:500-502
Is intensive glucose-lowering propitious to micro- and marcovascular complications?
LI Hong-liang;YANG Wen-ying
..............page:497-498
Initial results of IMPROVE study
SU Jie-ying;LI Hong-liang;YANG Wen-ying
..............page:495-496
Less brain insulin receptor substrate-2 (Irs2) signaling can extends the life span
HOU Zhi-qiang;LI Hong-liang;LI Guang-wei
..............page:494-495
Arguments and gains from the ADA 68th scientific sessions
YANG Wen-ying
..............page:493